Fulgent Genetics Inc Equity-NMS: FLGT

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$52.41

52W high :

$109.55

1Y :

-44.75%

5Y :

789.17%

Shares O/S :

30.33 M

Market cap :

1.62 B

What is the share price of Fulgent Genetics Inc today?

Fulgent Genetics Inc (FLGT) share price as of August 15, 2022, is $53.26. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Fulgent Genetics Inc?

Yes, Indian Investors can invest in the Fulgent Genetics Inc (FLGT) Share by opening an international trading account with Angel One.

How can I purchase Fulgent Genetics Inc shares in India?

Purchasing Fulgent Genetics Inc (FLGT) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Fulgent Genetics Inc (FLGT) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Fulgent Genetics Inc?

Yes, you can purchase fractional shares of Fulgent Genetics Inc (FLGT) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Fulgent Genetics Inc?

The market capitalization of Fulgent Genetics Inc on August 16, 2022, is $1.62 B.

In which sector Fulgent Genetics Inc belongs?

Fulgent Genetics Inc operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in Fulgent Genetics Inc stocks?

In order to invest in Fulgent Genetics Inc (FLGT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Fulgent Genetics, Inc. is a technology company, which offers COVID-19 testing services, molecular diagnostic testing services and comprehensive genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the patient care quality. The Company develops a technology platform, which offers a test menu. It performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. It also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.